Yuyu Pharma, Inc.(KR:000220)
₩3,795.00-5.00 (-0.13%)
KR:000220
Yuyu Pharma, Inc. financials statements
₩3,795.00
At close:-5.00 (-0.13%)
Want to see KR:000220 full AI Analyst Report?
Yuyu Pharma, Inc. (000220) Income Statement
Yuyu Pharma, Inc. Income Statement
Last quarter (Q2 2026), Yuyu Pharma, Inc.'s total revenue was ₩36.70B, an increase of 2.37% from the same quarter last year. In Q2, Yuyu Pharma, Inc.'s net income was ₩3.65B. See Yuyu Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 140.88B | ₩ 133.15B | ₩ 137.21B | ₩ 138.88B | ₩ 115.66B | |
| ₩ 53.94B | ₩ 51.70B | ₩ 48.53B | ₩ 53.31B | ₩ 45.34B | |
| ₩ 42.92B | ₩ 40.01B | ₩ 47.25B | ₩ 53.91B | ₩ 44.14B | |
| Depreciation and Amortization | ₩ 5.61B | ₩ 5.67B | ₩ 5.61B | ₩ 5.03B | ₩ 4.50B |
| ₩ 16.63B | ₩ 18.87B | ₩ 4.86B | ₩ 3.40B | ₩ 6.30B | |
| ₩ 11.02B | ₩ 11.70B | ₩ 364.54M | ₩ 691.75M | ₩ 2.65B | |
| ₩ -1.54B | ₩ -1.71B | ₩ -5.81B | ₩ -3.22B | ₩ -3.04B | |
| ₩ 9.48B | ₩ 9.98B | ₩ -5.44B | ₩ -3.81B | ₩ -383.16M | |
| ₩ 8.15B | ₩ 8.72B | ₩ -7.18B | ₩ -4.43B | ₩ -920.29M | |
| Per Share Metrics | |||||
| Basic EPS | ₩ 492.00 | ₩ 468.10 | ₩ -441.41 | ₩ -266.90 | ₩ -57.67 |
| Diluted EPS | ₩ 463.00 | ₩ 450.80 | ₩ -441.41 | ₩ -266.90 | ₩ -57.67 |
| Weighted Average Shares Outstanding | 16.59M | 16.18M | 16.27M | 16.58M | 15.96M |
| Weighted Average Shares Outstanding (Diluted) | 16.84M | 16.80M | 16.27M | 16.58M | 15.96M |
Currency in KRW

